|

Amcenestrant + Abemaciclib Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Amcenestrant (SAR439859), Abemaciclib (Verzenio)

Pipeline

Phase 2: 1

Top Sponsors

  • QuantumLeap Healthcare Collaborative1

Indications

  • Hormone Receptor Negative Tumor1
  • Hormone Receptor Positive Tumor1
  • Angiosarcoma1
  • TNBC - Triple-Negative Breast Cancer1
  • Locally Advanced Breast Cancer1

Birmingham, Alabama1 trial

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

University of Alabama at Birmingham

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.